[ Price : $8.95]
Vinay Prasad returns as CBER head at FDA commissioner Marty Makarys request after gaining White House approval.[ Price : $8.95]
Novartis says that it will seek FDA approval of its investigational drug ianalumab after it met the primary endpoint in two Phase ...[ Price : $8.95]
FDA accepts for priority review a GSK supplemental NDA for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoe...[ Price : $8.95]
IO Biotech says its investigational cancer vaccine Cylembio (imsapepimut and etimupepimut, adjuvanted), combined with Mercks Keytr...[ Price : $8.95]
FDA approves Nyxoahs Genio system, a hypoglossal nerve stimulation therapy for certain patients with moderate to severe obstructiv...[ Price : $8.95]
FDA investigators cite seven GMP deficiencies from an inspection conducted last month at a Dr. Reddys drug manufacturing plant in ...[ Price : $8.95]
FDA accepts for review an Arvinas and Pfizer NDA for vepdegestrant, a first-in-class oral PROteolysis TArgeting Chimera therapy fo...[ Price : $8.95]
FDA approves PharmaThers KETARx (ketamine), indicated for use in treating surgical pain.